Ebpay生命医药出版社

  • Ebpay生命

    102494

    论文已发表

    提 交 论 文


    注册即可获取Ebpay生命的最新动态

    注 册



    IF 收录期刊



    • 3.3 Breast Cancer (Dove Med Press)
    • 3.4 Clin Epidemiol
    • 2.5 Cancer Manag Res
    • 2.9 Infect Drug Resist
    • 3.5 Clin Interv Aging
    • 4.7 Drug Des Dev Ther
    • 2.7 Int J Chronic Obstr
    • 6.6 Int J Nanomed
    • 2.5 Int J Women's Health
    • 2.5 Neuropsych Dis Treat
    • 2.7 OncoTargets Ther
    • 2.0 Patient Prefer Adher
    • 2.3 Ther Clin Risk Manag
    • 2.5 J Pain Res
    • 2.8 Diabet Metab Synd Ob
    • 2.8 Psychol Res Behav Ma
    • 3.0 Nat Sci Sleep
    • 1.8 Pharmgenomics Pers Med
    • 2.7 Risk Manag Healthc Policy
    • 4.2 J Inflamm Res
    • 2.1 Int J Gen Med
    • 4.2 J Hepatocell Carcinoma
    • 3.7 J Asthma Allergy
    • 1.9 Clin Cosmet Investig Dermatol
    • 2.7 J Multidiscip Healthc



    更多详情 >>





    已发表论文

    基于动态对比增强磁共振成像的肿瘤内及肿瘤周影像组学预测单发肝细胞癌(≤3 厘米)微血管侵犯分级

     

    Authors Li Y , Li H, Feng Y, Lu L, Zhang J, Jia N 

    Received 13 February 2025

    Accepted for publication 17 May 2025

    Published 30 May 2025 Volume 2025:12 Pages 1083—1095

    DOI http://doi.org/10.2147/JHC.S519578

    Checked for plagiarism Yes

    Review by Single anonymous peer review

    Peer reviewer comments 2

    Editor who approved publication: Dr David Gerber

    Yinqiao Li,* Helin Li,* Yayuan Feng, Lun Lu, Juan Zhang, Ningyang Jia

    Department of Radiology, Eastern Hepatobiliary Surgery Hospital, Third Affiliated Hospital of Naval Medical University, Shanghai, 200438, People’s Republic of China

    *These authors contributed equally to this work

    Correspondence: Juan Zhang; Ningyang Jia, Department of Radiology, Eastern Hepatobiliary Surgery Hospital, Third Affiliated Hospital of Naval Medical University, Shanghai, 200438, People’s Republic of China, Email zhangjuan0801@126.com; ningyangjia@163.com

    Purpose: To explore the application value of clinical indicators, radiological features, and magnetic resonance imaging (MRI) radiomics to predict the grading of MVI in nodular hepatocellular carcinoma (≤ 3cm).
    Methods: A total of 131 patients with hepatocellular carcinoma (HCC) and confirmed microvascular invasion (MVI) who underwent surgical resection between January 2016 and December 2022 were retrospectively analyzed. A clinical-radiological (CR) model was constructed using independent risk factors identified by logistic regression. Radiomics models based on MRI (arterial phase, portal venous phase, delayed phase) across various regions (AVDPintra, AVDPintra+peri3mm, AVDPintra+peri5mm, AVDPintra+peri10mm) were developed using the Logistic Regression (LR) classifiers. The optimal radiomics model was subsequently integrated with the CR model to construct a combined clinical-radiological-radiomics (CRR) model. Model performance was assessed using the area under the curve (AUC).
    Results: Non-smooth margin and intratumoral artery were risk factors for MVI grading. The combined CRR model demonstrated the best predictive performance, with AUCs of 0.907 and 0.917 in the training and testing sets, respectively. Compared with the CR model alone, the CRR model showed a statistically significant improvement (p = 0.008, DeLong test).
    Conclusion: The AVDPintra+peri3mm model based on MRI radiomics demonstrates good predictive performance in predicting MVI grading in HCC (≤ 3cm). Combining features from the CR model with those of the AVDPintra+peri3mm model to construct the CRR model further enhances the prediction of MVI grading.

    Keywords: hepatocellular carcinoma, magnetic resonance imaging, radiomics, microvascular invasion grading

    Download Article[PDF]